Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients: A Randomized Controlled Clinical Trial

NCT04941131 is registered in ClinicalTrials.gov with King Abdulaziz University as lead sponsor.

NCT NCT04941131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04941131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients: A Randomized Controlled Clinical Trial
Lead sponsor
King Abdulaziz University
Phase
Phase 4
Overall status
Completed
Start date
May 18, 2023
Completion date
August 20, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19